Nocdurna
Indicated to manage nocturia to alleviate nocturnal polyuria symptoms.
Strengths: 0.2mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Desmomelt; DDAVP
- Therapeutic class
Vasopressin analogue
- Pharmacological class
Antidiuretic agent
- Minor side effects
dry mouth; headache; dizziness; nausea
- Moderate side effects
peripheral oedema; hyponatraemia
- Dosage forms
Orodispersible tablet
- Administration route
Sublingual use
- Patient summary
Indicated to manage nocturia to alleviate nocturnal polyuria symptoms.
- Prescription status
POM
- Manufacturer
Ferring Pharmaceuticals
- Onset Time
30–60 minutes
- Duration
8–12 hours
- Storage instructions
Store in original packaging at room temperature.
- Drug interactions
Tricyclic antidepressants; NSAIDs; Carbamazepine
- Age restrictions
Generally used in adults.
Contraindications
habitual polydipsia; known hyponatraemia; severe bladder dysfunction; moderate to severe renal impairment; cardiac insufficiency
Precautions and warnings
monitor serum sodium levels; restrict fluid intake one hour before and eight hours after administration; caution in elderly patients
Serious side effects
severe hyponatraemia — requires immediate medical attention; convulsions — requires immediate medical attention
Mechanism of action
Desmopressin mimics the action of antidiuretic hormone, increasing water reabsorption in the distal renal tubules and collecting ducts, thus decreasing urine production.
Pregnancy and breastfeeding
Pregnancy: Use with caution. Breastfeeding: Potential for excretion in breast milk; consult a physician.
Nocdurna
Indicated to manage nocturia to alleviate nocturnal polyuria symptoms.
Editorial Notes
- Active ingredient(s): Desmopressin
- Listed indication(s): Nocturia
Available option
- 30 tablets - 0.2 mg1472-0-2-mg-17749